109 related articles for article (PubMed ID: 23044159)
1. A case of childhood T cell acute lymphoblastic leukemia with a complex t(9;9) and homozygous deletion of CDKN2A gene associated with a Philadelphia-positive minor subclone.
Ney-Garcia DR; Vieira TP; Liehr T; Bhatt S; de Souza MT; de Figueiredo AF; Ribeiro RC; Silva ML
Blood Cells Mol Dis; 2013 Feb; 50(2):131-3. PubMed ID: 23044159
[No Abstract] [Full Text] [Related]
2. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case.
Kim HJ; Woo HY; Koo HH; Tak EY; Kim SH
Am J Hematol; 2004 Aug; 76(4):360-3. PubMed ID: 15282669
[TBL] [Abstract][Full Text] [Related]
3. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].
Sugiura I
Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762
[No Abstract] [Full Text] [Related]
4. Detection and clinical relevance of BCR-ABL fusion gene in childhood T-lineage acute lymphoblastic leukemia: a report on 4 cases.
Sazawal S; Bakhshi S; Raina V; Swaroop C; Saxena R
J Pediatr Hematol Oncol; 2009 Nov; 31(11):850-2. PubMed ID: 19816207
[TBL] [Abstract][Full Text] [Related]
5. Hyperdiploidy with trisomy 9 and deletion of the CDKN2A locus in T-cell acute lymphoblastic leukemia.
Healey K; Gray SL; Halligan GE; McKenzie AS; de Chadarévian JP; Morrissette JJ
Cancer Genet Cytogenet; 2009 Apr; 190(2):121-4. PubMed ID: 19380031
[TBL] [Abstract][Full Text] [Related]
6. BCR/ABL fusion gene detected in acute promyelocytic leukemia: a case study of clinical and laboratory results.
Sun X; He Y; Mao C; Zhu L; Qin X; Huang S
Leuk Lymphoma; 2014 Feb; 55(2):435-8. PubMed ID: 23772664
[No Abstract] [Full Text] [Related]
7. Chronic myelogenous leukemia in accelerated phase.
Huang Q
Arch Pathol Lab Med; 2005 May; 129(5):710. PubMed ID: 15859653
[No Abstract] [Full Text] [Related]
8. t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis.
Tan J; Cang S; Seiter K; Primanneni S; Ahmed N; Mathews T; Liu D
Cancer Invest; 2009 Aug; 27(7):718-22. PubMed ID: 19308813
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into the Philadelphia translocation.
Heisterkamp N; Groffen J
Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
[TBL] [Abstract][Full Text] [Related]
10. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
11. Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL.
Jarosová M; Mihál V; Holzerová M; Jedlicková K; Pospisilová ; Pikalová Z; Indrák K
Leukemia; 2000 Jul; 14(7):1319-22. PubMed ID: 10914561
[No Abstract] [Full Text] [Related]
12. BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia.
Fosså A; Siebert R; Kasper C; Becher R; Opalka B; Thiel E; Seeber S; Nowrousian MR
Br J Haematol; 1996 May; 93(2):403-5. PubMed ID: 8639438
[TBL] [Abstract][Full Text] [Related]
13. [Acute lymphoblastic leukemia with T + PH1 monocytosis: a case report].
Braham Jmili N; Sendi H; Khelif A
Ann Biol Clin (Paris); 2011; 69(4):473-5. PubMed ID: 21896415
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Milone JH; Enrico A
Leuk Lymphoma; 2009 Dec; 50 Suppl 2():9-15. PubMed ID: 20017606
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
[TBL] [Abstract][Full Text] [Related]
17. ABL-specific tyrosine kinase inhibitor imatinib as salvage therapy in a child with Philadelphia chromosome-positive acute mixed lineage leukemia (AMLL).
Selle B; Bär C; Hecker S; Schmidt-Rohr U; Viehmann S; Debatin KM; Reinhardt D
Leukemia; 2002 Jul; 16(7):1393-5. PubMed ID: 12094266
[No Abstract] [Full Text] [Related]
18. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
19. Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.
Van Hest RM; Schnog JB; Van't Veer MB; Cornelissen JJ
Am J Hematol; 2008 Sep; 83(9):757-8. PubMed ID: 18615671
[No Abstract] [Full Text] [Related]
20. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
